324 related articles for article (PubMed ID: 36933095)
1. The chaperone system in cancer therapies: Hsp90.
Basset CA; Conway de Macario E; Leone LG; Macario AJL; Leone A
J Mol Histol; 2023 Apr; 54(2):105-118. PubMed ID: 36933095
[TBL] [Abstract][Full Text] [Related]
2. The Chaperone System in Salivary Glands: Hsp90 Prospects for Differential Diagnosis and Treatment of Malignant Tumors.
Basset CA; Rappa F; Barone R; Florena AM; Porcasi R; Conway de Macario E; Macario AJL; Leone A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012578
[TBL] [Abstract][Full Text] [Related]
3. The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90.
Alberti G; Vergilio G; Paladino L; Barone R; Cappello F; Conway de Macario E; Macario AJL; Bucchieri F; Rappa F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887137
[TBL] [Abstract][Full Text] [Related]
4. Molecular Chaperones and Thyroid Cancer.
Paladino L; Vitale AM; Santonocito R; Pitruzzella A; Cipolla C; Graceffa G; Bucchieri F; Conway de Macario E; Macario AJL; Rappa F
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919591
[TBL] [Abstract][Full Text] [Related]
5. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
[TBL] [Abstract][Full Text] [Related]
6. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
7. Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity.
Backe SJ; Woodford MR; Ahanin E; Sager RA; Bourboulia D; Mollapour M
Subcell Biochem; 2023; 101():319-350. PubMed ID: 36520312
[TBL] [Abstract][Full Text] [Related]
8. Hsp90: a chaperone for protein folding and gene regulation.
Zhao R; Houry WA
Biochem Cell Biol; 2005 Dec; 83(6):703-10. PubMed ID: 16333321
[TBL] [Abstract][Full Text] [Related]
9. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
10. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Li J; Soroka J; Buchner J
Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
[TBL] [Abstract][Full Text] [Related]
11. Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.
Shevtsov M; Multhoff G; Mikhaylova E; Shibata A; Guzhova I; Margulis B
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652993
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
Siegelin MD
Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
[TBL] [Abstract][Full Text] [Related]
13. Probing molecular mechanisms of the Hsp90 chaperone: biophysical modeling identifies key regulators of functional dynamics.
Dixit A; Verkhivker GM
PLoS One; 2012; 7(5):e37605. PubMed ID: 22624053
[TBL] [Abstract][Full Text] [Related]
14. Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen.
O'Meara TR; O'Meara MJ; Polvi EJ; Pourhaghighi MR; Liston SD; Lin ZY; Veri AO; Emili A; Gingras AC; Cowen LE
PLoS Biol; 2019 Jul; 17(7):e3000358. PubMed ID: 31283755
[TBL] [Abstract][Full Text] [Related]
15. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modifications of Hsp90 and translating the chaperone code.
Backe SJ; Sager RA; Woodford MR; Makedon AM; Mollapour M
J Biol Chem; 2020 Aug; 295(32):11099-11117. PubMed ID: 32527727
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
Bohush A; Bieganowski P; Filipek A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
[TBL] [Abstract][Full Text] [Related]
18. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
19. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
Blair LJ; Sabbagh JJ; Dickey CA
Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
[TBL] [Abstract][Full Text] [Related]
20. A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand.
Backe SJ; Sager RA; Regan BR; Sit J; Major LA; Bratslavsky G; Woodford MR; Bourboulia D; Mollapour M
Cell Rep; 2022 Jul; 40(2):111039. PubMed ID: 35830801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
